Vivos Therapeutics, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Vivos Therapeutics, Inc. (VVOS) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $4.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-04-15
- Vivos Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $4.60M, a 318.18% increase from fiscal 2024.
- Vivos Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $1.10M, a 70.27% decline from fiscal 2023.
- Vivos Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $3.70M, a 22.92% decline from fiscal 2022.
- Vivos Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $4.80M, a 2.04% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $4.60M 10-K · filed 2026-04-15 |
| 2024-12-31 | $1.10M 10-K · filed 2026-04-15 |
| 2023-12-31 | $3.70M 10-K · filed 2025-03-31 |
| 2022-12-31 | $4.80M 10-K/A · filed 2024-07-30 |
| 2021-12-31 | $4.90M 10-K · filed 2022-03-31 |
| 2020-12-31 | $1.07M 10-K · filed 2021-03-25 |
| 2019-12-31 | $2.32M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |